A1C Gear System
Assay, Glycosylated Hemoglobin. 510(k) K130014, from Sakae Corporation (Los Angeles, CA). Product code LCP, class 2.
As of Nov 19, 2026, K130014 is an FDA 510(k) held by Sakae Corporation, substantially equivalent on Apr 4, 2014 after 457 days, with no recalls tied to it in FDA's recall database.
- Review time: 457 days
- Recalls: 0
- Cited as a predicate by: 1 device
The A1c GEAR System is intended for in vitro diagnostic use only for the quantitative measurement of the percent hemoglobin A1c (%HbA1c) from finger-stick blood or venous whole blood collected in either EDTA or sodium fluoride (NaF) for clinical laboratory and point of care use.
- Dca Vantage, Model 5075K071466 · Siemens Medical Solutions Diagnostics · Oct 9, 2007
- A1c iGear SystemK142789 · Sakae Corporation · Dec 16, 2014
- Q-Pad Test SystemK231465 · Qurasense · Dec 6, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jan 2, 2013
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7470
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files